← All stocks

BridgeBio Pharma, Inc.

BBIO No buying or selling

CIK 0001743881 #743 in the set updated 21 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

19 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

VIKING GLOBAL INVESTORS LP entity

10% owner

—

18,555,375

$1.59B

−26.1%

KKR Genetic Disorder L.P.

10% owner

—

13,260,971

$1.14B

−47.5%

HOMCY CHARLES J

Director

—

919,876

$78.79M

−25.2%

Kumar Neil

Chief Executive Officer

—

749,013

$64.15M

−71.1%

MCCORMICK FRANK

Director

—

690,558

$59.15M

−32.5%

Trimarchi Thomas

President and CFO

—

336,529

$28.82M

−15.0%

Satvat Ali J.

Director

—

169,983

$14.56M

—

Apuli Maricel

Chief Accounting Officer

—

122,687

$10.51M

−2.3%

STEPHENSON BRIAN C

CFO and Treasurer

—

102,464

$8.78M

+20.1%

Lo Andrew

Director

—

68,662

$5.88M

−72.9%

Hassan Fred

Director

—

29,879

$2.56M

+54.8%

Ellis Andrea

Director

—

22,579

$1.93M

+88.2%

DANIELS RONALD J

Director

—

20,981

$1.80M

+101.7%

MOMTAZEE JAMES C

Director

—

19,070

$1.63M

+124.6%

Scott Randal W.

Director

—

11,589

$992.60K

+131.8%

Dachille Douglas A.

Director

—

10,579

$906.09K

—

AGUIAR ERIC

Director

—

10,579

$906.09K

—

Valantine Hannah

Director

—

9,657

$827.12K

+61.5%

Cook Jennifer E.

Director

—

8,383

$718.00K

+17.2%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

BridgeBio Pharma, Inc.

By person

Individual transactions

What was left out